• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外膜肺氧合患者中活化部分凝血活酶时间(aPTT)引导与多模式肝素监测方法的评估:一项回顾性队列研究。

Evaluation of an aPTT guided versus a multimodal heparin monitoring approach in patients on extra corporeal membrane oxygenation: A retrospective cohort study.

作者信息

Taha Diman, Drop Joppe G, Wildschut Enno D, De Hoog Matthijs, van Ommen C Heleen, Reis Miranda Dinis Dos

机构信息

Department of Adult Intensive Care, Erasmus Medical Center, Rotterdam, the Netherlands.

Department of Pediatric Hematology, Sophia Children's Hospital, Erasmus Medical Center, Rotterdam, The Netherlands.

出版信息

Perfusion. 2025 Apr;40(3):557-567. doi: 10.1177/02676591241253474. Epub 2024 May 13.

DOI:10.1177/02676591241253474
PMID:38739366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11951356/
Abstract

IntroductionBleeding and thrombotic complications are common in extracorporeal membrane oxygenation (ECMO) patients and are associated with increased mortality and morbidity. The optimal anticoagulation monitoring protocol in these patients is unknown. This study aims to compare the incidence of thrombotic and hemorrhagic complications before and after a protocol change. In addition, the association between hemostatic complications, coagulation tests and risk factors is evaluated.MethodsThis is a retrospective single center cohort study of adult ECMO patients. We collected demographics, ECMO parameters and coagulation test results. Outcomes of the aPTT guided and multimodal protocol, including aPTT, anti-Xa assay and rotational thromboelastometry were compared and the association between coagulation tests, risk factors and hemostatic complications was determined using a logistic regression analysis for repeated measurements.ResultsIn total, 250 patients were included, 138 in the aPTT protocol and 112 in the multimodal protocol. The incidence of thrombosis (aPTT: 14%; multimodal: 12%) and bleeding (aPTT: 36%; multimodal: 40%), did not significantly differ between protocols. In the aPTT guided protocol, the aPTT was associated with thrombosis (Odds Ratio [OR] 1.015; 95% confidence interval [CI] 1.004-1.027). In both protocols, surgical interventions were risk factors for bleeding and thrombotic complications (aPTT: OR 93.2, CI 39.9-217.6; multimodal OR 17.5, CI 6.5-46.9).DiscussionThe incidence of hemostatic complications was similar between both protocols and surgical interventions were a risk factor for hemostatic complications. Results from this study help to elucidate the role of coagulation tests and risk factors in predicting hemostatic complications in patients undergoing ECMO support.

摘要

引言

出血和血栓形成并发症在体外膜肺氧合(ECMO)患者中很常见,且与死亡率和发病率增加相关。这些患者的最佳抗凝监测方案尚不清楚。本研究旨在比较方案改变前后血栓形成和出血并发症的发生率。此外,还评估了止血并发症、凝血试验和危险因素之间的关联。

方法

这是一项针对成年ECMO患者的回顾性单中心队列研究。我们收集了人口统计学资料、ECMO参数和凝血试验结果。比较了活化部分凝血活酶时间(aPTT)指导方案和多模式方案的结果,包括aPTT、抗Xa测定和旋转血栓弹力图,并使用重复测量的逻辑回归分析确定凝血试验、危险因素和止血并发症之间的关联。

结果

总共纳入了250例患者,138例采用aPTT方案,112例采用多模式方案。两种方案之间血栓形成(aPTT方案:14%;多模式方案:12%)和出血(aPTT方案:36%;多模式方案:40%)的发生率无显著差异。在aPTT指导方案中,aPTT与血栓形成相关(比值比[OR]1.015;95%置信区间[CI]1.004 - 1.027)。在两种方案中,手术干预都是出血和血栓形成并发症的危险因素(aPTT方案:OR 93.2,CI 39.9 - 217.6;多模式方案OR 17.5,CI 6.5 - 46.9)。

讨论

两种方案的止血并发症发生率相似,手术干预是止血并发症的危险因素。本研究结果有助于阐明凝血试验和危险因素在预测接受ECMO支持患者的止血并发症中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0169/11951356/5ccbae5bcc7c/10.1177_02676591241253474-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0169/11951356/1e9e3371f15b/10.1177_02676591241253474-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0169/11951356/5ccbae5bcc7c/10.1177_02676591241253474-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0169/11951356/1e9e3371f15b/10.1177_02676591241253474-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0169/11951356/5ccbae5bcc7c/10.1177_02676591241253474-fig2.jpg

相似文献

1
Evaluation of an aPTT guided versus a multimodal heparin monitoring approach in patients on extra corporeal membrane oxygenation: A retrospective cohort study.体外膜肺氧合患者中活化部分凝血活酶时间(aPTT)引导与多模式肝素监测方法的评估:一项回顾性队列研究。
Perfusion. 2025 Apr;40(3):557-567. doi: 10.1177/02676591241253474. Epub 2024 May 13.
2
Evaluation of a pharmacy managed heparin protocol for extracorporeal membrane oxygenation patients.评估用于体外膜肺氧合患者的药房管理肝素方案。
Perfusion. 2017 Apr;32(3):238-244. doi: 10.1177/0267659116678057. Epub 2016 Nov 11.
3
Performance Assessment of a Multifaceted Unfractionated Heparin Dosing Protocol in Adult Patients on Extracorporeal Membrane Oxygenator.在体外膜肺氧合患者中使用多方面未分级肝素给药方案的性能评估。
Ann Pharmacother. 2021 May;55(5):592-604. doi: 10.1177/1060028020960409. Epub 2020 Sep 22.
4
Use of rotational thromboelastometry to predict hemostatic complications in pediatric patients undergoing extracorporeal membrane oxygenation: A retrospective cohort study.使用旋转血栓弹力图预测接受体外膜肺氧合治疗的儿科患者的止血并发症:一项回顾性队列研究。
Res Pract Thromb Haemost. 2021 Jul 14;5(5):e12553. doi: 10.1002/rth2.12553. eCollection 2021 Jul.
5
The Impact and Statistical Analysis of a Multifaceted Anticoagulation Strategy in Children Supported on ECMO: Performance and Pitfalls.体外膜肺氧合(ECMO)支持下儿童多方面抗凝策略的影响及统计分析:效果与问题
J Intensive Care Med. 2017 Jan;32(1):59-67. doi: 10.1177/0885066615601977. Epub 2015 Aug 28.
6
Bleeding, Thrombosis, and Transfusion With Two Heparin Anticoagulation Protocols in Venoarterial ECMO Patients.两种肝素抗凝方案在静脉动脉体外膜肺氧合患者中的出血、血栓形成和输血。
J Cardiothorac Vasc Anesth. 2019 May;33(5):1216-1220. doi: 10.1053/j.jvca.2018.07.045. Epub 2018 Aug 3.
7
Evaluation of Anti-Xa and Activated Partial Thromboplastin Time Monitoring of Heparin in Adult Patients Receiving Extracorporeal Membrane Oxygenation Support.评估成人患者接受体外膜肺氧合支持时肝素的抗 Xa 和活化部分凝血活酶时间监测。
ASAIO J. 2020 Mar;66(3):300-306. doi: 10.1097/MAT.0000000000001004.
8
Anti-factor Xa vs aPTT for heparin monitoring in extracorporeal membrane oxygenation.抗因子 Xa 与 aPTT 在体外膜肺氧合中监测肝素的比较。
Am J Health Syst Pharm. 2023 May 24;80(Suppl 2):S77-S83. doi: 10.1093/ajhp/zxac351.
9
Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.仅采用预防性皮下抗凝的静脉-静脉体外膜肺氧合:一项针对60多名患者的观察性研究。
Artif Organs. 2017 Feb;41(2):186-192. doi: 10.1111/aor.12737. Epub 2016 Jun 3.
10
Low Versus Standard Intensity Heparin Protocols in Adults Maintained on Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study.体外膜肺氧合维持下成人低强度与标准强度肝素方案对比:一项回顾性队列研究
J Pharm Pract. 2025 Jun;38(3):299-304. doi: 10.1177/08971900241285248. Epub 2024 Sep 20.

本文引用的文献

1
Effect of Initial Anticoagulation Targets on Bleeding and Thrombotic Complications for Patients With Acute Respiratory Distress Syndrome Receiving Extracorporeal Membrane Oxygenation.体外膜肺氧合治疗急性呼吸窘迫综合征患者的初始抗凝目标对出血和血栓并发症的影响。
J Cardiothorac Vasc Anesth. 2022 Sep;36(9):3561-3569. doi: 10.1053/j.jvca.2022.05.012. Epub 2022 May 13.
2
Risk factors and outcomes for patients with bleeding complications receiving extracorporeal membrane oxygenation: An analysis of the Chinese Extracorporeal Life Support Registry.接受体外膜肺氧合治疗的患者发生出血并发症的风险因素和结局:中国体外生命支持注册研究的分析。
Artif Organs. 2022 Dec;46(12):2432-2441. doi: 10.1111/aor.14321. Epub 2022 Jun 1.
3
Risk factors for bleeding complications during venovenous extracorporeal membrane oxygenation as a bridge to recovery.
静脉-静脉体外膜肺氧合作为恢复的桥梁期间出血并发症的风险因素。
Artif Organs. 2022 Sep;46(9):1901-1911. doi: 10.1111/aor.14267. Epub 2022 Apr 29.
4
Major Bleeding in Adults Undergoing Peripheral Extracorporeal Membrane Oxygenation (ECMO): Prognosis and Predictors.接受外周体外膜肺氧合(ECMO)治疗的成人严重出血:预后与预测因素
Crit Care Res Pract. 2022 Jan 15;2022:5348835. doi: 10.1155/2022/5348835. eCollection 2022.
5
Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: an ELSO registry analysis.体外膜肺氧合支持成人的出血和血栓事件:ELSO 登记分析。
Intensive Care Med. 2022 Feb;48(2):213-224. doi: 10.1007/s00134-021-06593-x. Epub 2021 Dec 18.
6
A Comparison of Anticoagulation Strategies in Veno-venous Extracorporeal Membrane Oxygenation.静脉-静脉体外膜肺氧合抗凝策略的比较
ASAIO J. 2022 May 1;68(5):738-743. doi: 10.1097/MAT.0000000000001560. Epub 2021 Aug 20.
7
Evaluation of a Multimodal Heparin Laboratory Monitoring Protocol in Adult Extracorporeal Membrane Oxygenation Patients.成人体外膜肺氧合患者多模式肝素实验室监测方案的评估
J Pharm Pract. 2023 Feb;36(1):79-86. doi: 10.1177/08971900211021249. Epub 2021 Jun 10.
8
Evaluation of Anti-Activated Factor X Activity and Activated Partial Thromboplastin Time Relations and Their Association with Bleeding and Thrombosis during Veno-Arterial ECMO Support: A Retrospective Study.静脉-动脉体外膜肺氧合支持期间抗活化因子X活性与活化部分凝血活酶时间关系及其与出血和血栓形成的相关性评估:一项回顾性研究
J Clin Med. 2021 May 17;10(10):2158. doi: 10.3390/jcm10102158.
9
Optimal Tests to Minimise Bleeding and Ischaemic Complications in Patients on Extracorporeal Membrane Oxygenation.优化体外膜肺氧合患者的出血和缺血并发症的检测方法。
Thromb Haemost. 2022 Apr;122(4):480-491. doi: 10.1055/a-1508-8230. Epub 2021 Jun 21.
10
Extracorporeal membrane oxygenation-a moving target.体外膜肺氧合——一个不断变化的目标。
Indian J Thorac Cardiovasc Surg. 2021 Apr;37(Suppl 2):193-195. doi: 10.1007/s12055-021-01187-0. Epub 2021 Apr 5.